Recent centuries have witnessed remarkable developments in the treatment of muscular dystrophy. Experts are actively investigating innovative methods that hold hope for improving the lives of individuals stricken by this progressive condition. Drug development have emerged as particularly promising directions for tackling the underlying mechanisms